Professor in molecular biotechnology, KTH – Royal Institute of Technology
New molecular tools for FTD studies
Development of protein based treatments for FTD
Professor Stefan Ståhl with research group develops specific affinity reagents against key disease-associated proteins. The aim is to be able to use the affinity proteins as effective research tools to study disease mechanisms behind FTD, and also as drug candidates for further development of treatments that may have preventive and/or curative effect of the disease.
For more information please visit the Stefan Ståhl group webpage: